こちら - 3D MATRIX [medical technology]
Contents
1. KOL Key Opinion Leader TOP http7 www sharedresearchjp 17 31 Shared Wesearch s se 201279 21 7777 http7 www sharedresearchjp 18 31 sShared 9esearch 201279 21 7777 2012 4 2012 6 132. DDS Drug Delivery System
3. 2012 9 5 http www 3d matix co jp dI_file 2012 3DM_2012_09_05_IR_001 pdf MIT
4. pH TDM 621
5. 2012 4 20123 4 TDM 621 http Awww sharedresearchjp 14731 Shared Wesearch sy 201279 21 7777
6. SR Inc SR nc http7www sharedresearchjp 31 31 Shared Wesearch
7. 2 MIT MIT 2014
8. DDS siRNA PuraMatrix Becton Dickinson and Company
9. Scaffold GLP Good Laboratory Practice http Awww sharedresearchjp 28 31 Shared 8 esearch 201279 21 7777 pH
10. 2007 10 579 1 448 3DM Investmen LLC Massachusetts Insttute of Technology 2009 11 500 1 250 4 JAIC TAIB JAIC Asian Balanced Private Equity Fund 2010 9 200 400 m 2010 9 300 600
11. pH bFGF PDGF PuraMatrix R A D 16 RADA16
12. TDM 64 1 TDM 64 1 3 TDM 641 IITTITIDEL TO JITTTFIIII TDM 641 TDM 621 RADA16 TDM 621
13. 2015 4 2015 4 http7www sharedresearchjp 4731 Shared Wesearch sy 201279 21 7777 m TDM 621 2013 4 2013 4
14. MIT Ed 1 2 3 3
15. http7www sharedresearchjp 6731 Shared Wesearch 201279 21 7777 DDS
16. TDM 621 TDM 621 4 http7 wWww sharedresearchjp 9731 Shared Wesearch s 201279 21 7777 TDM 621 Informed Consent 12 2 _ 2
17. TDM 621 1 Informed Consent 2 3 TDM 621
18. 2 http7 www sharedresearchjp 29 31 sShared 9esearch 201279 21 7777 TOP TOP http7 www sharedresearchjp 30 31 sShared 9esearch 2012 9 21 7777
19. 2009 7 2009 8 PMDA 2010 1 2010 8 13B1X10105 3 D Matrix Inc IDE FDA Daewoong Pharmaceutical Co LTD PARTNERSHIP AGREEMENT 2009 4 2010 9 Excelsior Medical Co Ltd LICENSE AGREEMENT
20. 2004 5 2004 10 3 DMatrix Inc LICENSE AND SUPPLY AGREEMENT 3 D Matix Inc MIT MIT Scientfic Founders 2007 10 3 D Matrix Inc http7 www sharedresearchjp 24 31 sShared 9esearch 201279 21 7777 1992 MIT Shuguang Zhang 2001 5 MT 3 D Matrix Inc 3 D Matix Inc
21. m 2015 4 SR 2015 4 2011 10 2012 6 2017 4M LE 1 991 ee 2013 4m 2014 4mA 2015 4MA 2016 4mN 2017 4mM a
22. 1 4521 TDM 621 PMDA CE EU EU CE FDA
23. TDM 621 2010 1 97 2011 4 TDM 621 5 gt 7 2011 5 PMDA TDM 621
24. 434 18 452 498 79 10 46 7 TOP http7www sharedresearchjp 23 31 Shared esearch 201279 21 7777 Massachusetts Institute of Technology MIT Shuguang Zhang 2004 5 1992 MIT Shuguang Zhang MIT MIT 2001 5 3 D Matix Inc
25. a TDM 711 TDM 711 TDM 711 3 TDM 711
26. http7www sharedresearchjp 15731 Shared Wesearch 201279 21 7777 TOP RS s 7 000 200 5811 5 058 5g14 5 931 6 000 31 raat V7 FT oo 07 08 09 10 11 12 13 14 5 000 4 000 3 000 OE 2006 2007 2008 2009 9 mm
27. ADME 30 DDS MIT MIT PuraMatrix PuraMatrix KS 5 i HH EA EA a A RE mw
28. CSL amp 1 4502 2009 Medmarket Diligence 1 4503 lt 1 3401 gt CSL 1 4559
29. MIT m m SR Weaknesses m
30. 1 2012 gt gt a N 2012 US 3 2012 2012 2 lt a gt A a TDM 621
31. http7 www sharedresearchjp 8731 sShared 9esearch 201279 21 7777 1987 C 1 2008 1 30 2008 12 14 6 1 2009 11 30 2010 1 2007 12 160 2008 1 2009 3 TDM 621
32. D D Asp COOH NH2 A A Ala R R Arg ADME ADME Absorption Distributon Metabolism Excretion
33. 4 1992 MIT Shuguang Zhang R A D 3 RADA 16 pH
34. AH TOP SR
35. http www 3d matix co jp dI_file 2012 3DM_2012_09_06_IR_001 pdf Massachusetts Institute of Technology MIT m m 5057781 m MIT 3
36. PMDA PMDA 2011 5 2011 7 3 D Matrix Inc FDA 1DE 2012 2 2012 3 3 D Matrix Europe SAS 2012 4 3 D Matix Inc 2007 10 3 D Matix Inc 2009 4 TOP amp 2012 6 2
37. 4 MBA 1999 JASDAQ7774 2002 2370 COO 2003 10 2005 2007 1998
38. m CPC Scientfic Inc 3 3 TDM 621 2011 5 http7 www sharedresearchjp 12 31 sShared 9esearch 201279 21 7777 2009 4 1 8001
39. 2013 4 1 2012 9 13 2013 4 1 0 232 232 123 2012 4 25 TDM 621 TDM 621 PMDA TDM 621 1 4538
40. 6 2016 1 344 IDATA Research 30 509 2016 1 344M gm ipAr 1 600 M 1 400 1 200 1 000 800 600 400 200 0 CY06 CYO7 CYO8 CY09 CY10E CY11E CY12E CY13E CY14E CY15E CY16E SEALANTS mHEMOSTATS m 80 10 4 http7 www sharedresearchjp 16 731 Shared 9esearch s 201279 21 7777 m 113 685
41. 170 TDM 621 50 300
42. sr_inquiries sharedresearch jp 08 4 og 4 1o 4 11 4 12 4 13 4 10 10 402 158 1 107 2 491 805 2 4 5 60 5 5995 124 9 467 641 753 37 2 17 5 65 482 354 589 66 8 16 3 304 7 32 0 23 5 222 259 60 510 310 583 88 3 28 0 29 4 223 296 61 534 309 529 71 4 27 9 21 2 5 584 5 6534 6 784 7 584 9 178 EPS 39 9 525 90 70 4 368 57 4 EPS 345 DPS 00 00 00 00 00 00 BPS 1715 1219 172 0 150 2 312 6 544 589 1 758 594 666 2 501 7 6 88 19 22 30 578 505 437 986 733 1 198 1 199 3 055 12 16 22 0 0 0
43. TDM 64 1 2012 4 2012 2 c TDM 631 RADA16 TDM 631 TDM 631 TDM 631 TDM 631
44. 1 2005 2007 2012 7 INSEAD MBA TOP http7 www sharedresearchjp 26 31 sShared 9esearch 201279 21 7777 2012 4 22 19 39 9 2 7 TOP TR 2 4 TOP http7 www sharedresearchjp 27 31 sShared 9esearch 201279 21 7777 TDE Investigatonal Device Exempton FDA
45. 2010 9 FDA IDE 2011 7 IDE 2012 2 Forsytmh Institute 2012 6 15 FDA C DDS DDS DDS bDFGF PDGF A6K siRNA
46. 14 26 7 52 149 150 mm TDM 621 2011 5 PMDA TDM 621 1 4538 TDM 621 m
47. 400 190 210 204 204 m TDM 621 2011 4 1 PMDA TDM 621 TDM 621 m
48. PII II 1 2 3 TDM 621 2009 2013 4 3 lt 4
49. http www 3d matix co jp dI_file 2012 3DM_2012_07_31_IR_001 pdf RNA RNA 2013 4 2012 7 17 https www rele
50. 2010 8 2010 9 Daewoong Pharmaceutical Co LTD PARTNERSHIP AGREEMENT Excelsior Medical Co Ltd LICENSE AGREEMENT http7 www sharedresearchjp 20 31 sShared 9esearch 201279 21 7777 m TDM 711 2011 3 FDA IDE IDE 3 TOP 08 4 og 4 1o 4 11 4 12 4 13 4 Ez 10 10 402 158 1 107 2 491 8052 45 606 5995 124 9 1 2 3 398 111 233 251 533
51. gt TDM 711 TDM 711 GLP TDM 711
52. 1009 60 70 MIT SR CRO
53. 2012 4 2 2011 12 9 2012 4 2 2 400 TDM 621 400 341 59 9 9 2 535 2011 4 1 385 685 2011 10 24 JASDAQ 2011 10 23
54. MIT Exclusive Patent License Agreement 2003 4 2004 5 3 D Matrix Inc LICENSE AND SUPPLY AGREEMENT 3 D Matrix Inc PuraMatrix 2004 10 MR mp Matrix Inc 2008 2 Becton Dickinson and Company SUPPLY AGREEMENT PuraMatix RADA16 2008 3 2008 10
55. 2014 4 2013 4 2015 4 2013 4 CE EU EU CE 2014 4 2015 4 TDM 641 2013 4 2014 4 2015 4 TDM 631 _ 2014 4 2015 4 TDM 711 2012 2 2014 4 2015 4 mm
56. TDM 631 TDM 631 X B http7www sharedresearchjp 11731 Shared Wesearch 201279 21 7777
57. 2 3 7 TDM 621 TDM 711 TDM 641 TDM 631 TDM 621 RADA16 TDM 621 97 2012 4 m http7 www sharedresearchjp 7 31 sShared 9esearch 201279 21 7777
58. m TDM 711 2012 2 15 FDA m TDM 641 2013 4 mm 2012 2013 4 3731 http7 www sharedresearchjp sShared 9esearch 201279 21 7777 13 4 400 707 1 107 2 491 5995 1249 7 164 251 533 21 7 232 227 21 4 254 245 499 971
59. m m 507629 m MIT 2 2 3 2012 7 31 2012 360
60. SR 2014 MIT MIT MIT 2001 5 3 D Matrix Inc m 3 D Matrix Tnc 100 mm 3 D Matrix Europe SAS 100
61. MTA 3 III 1 1 2 TII 3
62. 2012 2012 2012 4 TDM 621 2010 9 17 Daewoong Pharmaceutical Co LTD PARTNERSHIP AGREEMENT Excelsior Medical Co Ltd LICENSE AGREEMENT 2012 2013 4 2015 4 2012 4 CE EU
63. TDM 621 1 000 MR 100 TDM 621 MR 700 2012 6 2011 10 1 902 152 5
64. 355 406 499 g71 467 641 753 1 902 65 482 354 589 663 320 236 11 0 3 5 27 48 222 259 60 510 310 583 888 281 234 3 1 21 1 223 296 61 534 309 529 4 279 212 SR 08 4 09 4 10 4 11 4 544 589 1 758 33 39 25 17 39 718 594 66G 2 501 7 6 88 19 22 30 537 467 397 42 38 40 578 505 437 604 533 554 986 733 1 198 1 199 3 055 12 16 22 4 24 30
65. MIT Rit A US 5670483 MT 1997 9 23 2014 11 29 i US 6548630 MIT 2008 4 15 2017 7 21 PuralMatrix WO 06 014570 _ _ 2008 816133 LM US 5955343 MTT 1999 9 21 2014 21 Mei US 6800481 MIT 2004 10 5 2017 3 25 SR US 7098028 MIT 2006 8 29 2023 3 16 1 lt US 7449180 20
66. RADA16 Ii lt Pc oe E gt I II YY A 1 _ A 10 SW Strengths Weaknesses Strengths m
67. RADA16 TDM 621 TDM 621 TDM 621 TDM 621 pH lt gt TDM B 1 TDM 621 C
68. ADME SiRNA 21 23 RNA siRNA RNA RNAi RNA mRNA MTA Material Transfer Agreement
69. 636 346 451 391 59 295 354 589 56M 14 41 5 320 236 9 301 310 583 883 23 425 281 234 9 300 309 529 7 4 SR 2 491 124 9 TDM 621 PMDA TDM 621 2012 4
70. TDM 711 2011 7 FDA IDE 2011 4 158 2010 4 402 ASG 150 2010 4 400 641 2010 4 174 50 TDM 621 122 482 2010 4 65 510 60 534 61 8 19 wm TDM 621 2010 4 2011 4 PMDA
71. TOP 3DM Investment LLC MIT 3 D Matrix Inc TOP TOP 3 D Matrix Inc 2004 3 D Matrix Inc 2000
72. 676 m TDM 621 2011 5 PMDA TDM 621 TDM 621 m TDM 711 2011 7 FDA 1IDE 2012 4 1 400 TDM 621
73. TDM 711 2011 7 FDA 1DE 2012 2 m TDM 641 2012 2 20 http7www sharedresearchjp 19731 Shared Wesearch 201279 21 7777 m 2011 Phase 1 mm
74. 2012 4 1 107 1 TDM 621 2 TDM 641 3 753 354 3 14 26 48 310 309 2012 4 300 m
75. 2769 09 05 12 7455 09 03 12 2593 09 07 12 2362 09 14 12 6063 08 28 12 2353 09 21 12 6157 08 31 12 8233 09 06 12 SR Inc SR Inc Shared Research SR Inc
76. 1 W aps 1 2 3 4 PMDA FDA 5 PMDA FDA 6
77. 31 49 112 0 0 0 0 0 55 31 49 167 958 687 1 167 1 150 2 888 0 0 0 28 434 131 13 18 100 573 498 1 400 RO amp y d4 6 34 5 6 3 44 6 14 5 ROE 36 0 36 0 6 6 46 3 15 4 97 1 93 7 97 4 95 0 93 9 SR http www sharedresearchjp 1731 Shared 9esearch w 201279 21 7777 2012 9 13 2013 4 1 htp www 3d matrix co jp dI_file 2012 3DM 2012_09_13_IR_001 pdf 2013 4 1 2012 9 6
78. 3046 09 05 12 2453 08 23 12 7777 09 20 12 9793 08 02 12 4819 09 11 12 7532 09 19 12 4571 08 10 12 6324 09 12 12 05 10 12 IS 4283 07 27 12 2767 08 30 12 6890 08 27 12 24 12 09 03 12 9904 09 10 12 944 1 09 06 12 3730 08 20 12 7541 09 03 12 2370 08 23 12 4680 09 07 12 4681 09 07 12 6920 08 31 12
79. 550 300 456 256 477 255 478 TDM 621 TDM 621 1 4538 1 4521 2012 4 9 TDM 621 TDM 621
80. 9 222 2012 6 445 200 445 200 2012 4 4 588 800 10 2012 9 TOP http7 www sharedresearchjp 22731 Shared 9esearch 2012 9 21 7777 08 4 09 4 10 4 11 4 12 4 1 28 2 13 FCF 1 2 40 573 a 75 B 11 Cc FCF NI A B C SR
81. MIT MIT 3 D Matrix Inc 2003 4 MIT Exclusive Patent License Agreement MIT 2004 10 3 D Matrix Inc License and Supply Agreement 3 D Matrix Inc 2007 10 3 D Matrix Inc 3 D Matrix Inc
82. 0 0 0 15 9 59 31 49 112 0 0 0 0 0 55 0 0 55 0 0 0 31 49 167 1 109 1 359 2 070 1 099 1 349 2 060 1 063 1 596 1 288 11 19 958 687 1 167 1 150 2 888 21 22 3 0 0 0 544 589 1 758 SR http7 Www sharedresearchjp 21731 Shared Wesearch 201279 21 7777 2012 4 3 D Matrix Inc 70 2019 4
83. TDM 621 2011 5 PMDA TDM 621 1 4538 2012 4 1 4521 m TDM 711 2011 7 FDA IDE 2012 2 Forsyth Insttute m TDM 641
84. TDM 621 2012 4 1 4521 TDM 621 1 000 MR 100 TDM 621 MR 700 Daewoong Pharmaceutical Co LTD Excelsior Medical Co Ltd Daewoong Pharmaceutcal Co LTD Exce
85. TOP http7www sharedresearchjp 5731 Shared Wesearch 201279 21 7777 Massachusetts Institute of Technology MIT 1 4 1 MTT MIT 2 3
86. EU CE 2013 4 CE 2015 4 2012 4 TDM 621 2011 5 1 4538 10
87. 11 526 m 60 10 5 6 Millennium Research Group 2 000 5 6 p 4y 1 400 Proprietary 8 0 1 200 1 Nonproprietary 1 9 1 000 25y S00 2 8 600 146 400 200 eo Milennium Research Group US Market for Dental Biomaterials 0 2010 2008 2009 2010 2011 2012 2013 2014 MIT
88. Ac R A D A R A D A R A D A R A D A CONH R A D 1 2 3 4 DDS
89. 2012 2 20 m 2011 Phase I 2012 4 3 2012 3 9 2012 4 3 3 400 TDM 621 400 498 98
90. 533 971 398 589 66 3 583 88 3 529 71 4 11 4 12 4 13 4 14 4 15 4 EE 158 1 107 2 491 3 845 8 006 233 251 533 692 776 406 499 g71 1 117 1 298 482 354 589 1 091 3 521 510 310 583 1 085 3 515 534 309 529 936 2 222 SR 2012
91. 6 14 2015 4 2 gt 3 2013 4 1 KOL Key Opinion Leader 2011 11 m 2014 4
92. PDF htp www sharedresearch jp 7777
93. SR 2012 9 21 3076 09 14 12 8423 08 07 12 6754 08 07 12 9882 08 03 12 4847 08 22 12 2492 08 16 12 6750 08 24 12 4849 08 24 12 HD 8016a 07 06 12 8016 08 06 12 4583 08 20 12 8060 08 06 12 4763 07 05 12 8999 08 17 12 6249 09 12 12 6287 08708 12 8136 09 11 12 3360 08 27 12
94. TDM 621 Daewoong Pharmaceutical Co LTD Excelsior Medical Co Ltd TDM 641 m 2 2012 4 100 MTA
95. 012 6 18 TDM 711 TDM 711 http7www sharedresearchjp 25 731 Shared Wesearch 201279 21 7777 Forsyth Insttute 2012 2 15 FDA 2012 4 2012 4 12 2012 4 1 100
96. 08 11 30 2021 2 5 2 EP 717398 MT 200g 12 1 2022 2 5 i PuralMatrix US 7713923 MIT 2010 5 11 2024 6 2 PuralMatrix US2005 0287186 MIT PCT SR http7www sharedresearchjp 13 7 31 Shared esearch 201279 21 7777 3 D Matrix jnc MT AlMENDED AND RESTATED EXCLUSTVE PATENT LICENSE AGREEMENT FIRST AMENDIMENT SECOND AMENDMENT THIRD AMENDMENT TO AMENDED AND ai oa MIT 3 D Matrix Inc MIT
97. Excelsior Medical Co Ltd Daewoong Pharmaceutical CO LTD 2011 10 1 352 700 1 08 4 09 4 10 4 11 4 Ez 70 70 5 95 4 5d8 8 EPS 394149 424004 7 706 58896 1 737 EPS 69 0 DFS 00 00 00 00 00 BPS 137 228 4 975028 137 6342 120 1595 625 1 5 584 5 634 6 784 584 9 178 EPS 39 9 525 9 0 70 4 368 EPS 345 DPS 00 00 00 00 00 BPS 1715 1219 172 0 150 2 312 6 SR m 2011 7 1 100 948 m 2011 8 1 4 3 792 m 2012 9 1 2
98. ase tdnetL info inbs 140120120717077135 pdf 2012 8 31 1 2 4 604 9 208 3 amp http7 www sharedresearchjp 2 31 sShared 9esearch 201279 21 7777 12 4 13 4 13 4 iQ 2Q 3Q 4Q 1Q 2Q 3Q 4Q 400 0 0 707 0 0 0 2 491 124 9 40 47 45 120 92 130 1 150 104 112 132 134 10 6 210 151 157 452 226 589 55 3 526 639 23 6 204 195 158 459 232 583 88 3 51 1 654 9 23 4W 204 196 159 459 232 529 ME 1 51 1 64 9 21 2 SR
99. lsior Medical Co Ltd 14 000 1cc SR b TDM 641 TDM 641 TDM 641 http7www sharedresearchjp 10731 Shared Wesearch 201279 21 7777
Download Pdf Manuals
Related Search